A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

Interesting targets for peptide vaccination have been defined including Wilms tumor gene 1 ... For the three aforementioned antigens, more and more epitope peptides have been defined.

A phase 1 study of a personalized cancer vaccine demonstrated antitumor immunity in all treated patients with resected renal ...

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...

No Derivatives (ND): Derivative works may be created for non-commercial purposes, but sharing is prohibited. In recent years, peptide-based therapies have gained remarkable attention as promising ...

Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...

Feb. 4, 2025 — A research team has identified a critical event driving tumor growth in a type of medulloblastoma -- and a way to block ... Routine Brain MRI Screening in Asymptomatic Late Stage ...

Blood tests are routinely used by veterinarians to monitor a dog’s health or help diagnose medical conditions. But often the ...

primary focus on cancer vaccines. The shot is the lead product candidate from BioNTech's FixVac platform and is based on a combination of four mRNA-encoded, melanoma-associated antigens – NY-ESO ...